Knoa Pharma's new CEO, Michael Goettler, will lead a company that was created through Purdue Pharma's bankruptcy process.

WASHINGTON - More than 11,000 bottles of a prescription medication used to treat high blood pressure have been recalled ...

CITY OF INDUSTRY, CA, UNITED STATES, June 29, 2026 /EINPresswire.com/ -- During formulation trials in a pharmaceutical ...

A large recall affects thousands of bottles of chlorthalidone, a common blood pressure drug used in the US. Regulators link ...

A blood pressure medication distributed by a New Jersey company has been voluntarily recalled, according to the U.S Food and Drug Administration. Chlorthalidone tablets — which are used to treat high ...

Chlorthalidone tablets from the manufacturer Inventia Healthcare Limited have been recalled due to failed dissolution ...

Over 11,0000 bottles of the blood pressure medication chlorthalidone have been recalled nationwide, according to the Food and Drug Administration (FDA). The FDA classified this as a Class II recall, ...

The Class II recall means the defective medication could cause temporary or medically reversible health problems for patients ...

Thousands of bottles of blood pressure medication are being pulled nationwide because of a manufacturing issue.

More than 11,000 bottles of blood pressure medication are being recalled over possibly failing dissolution specifications, according to the U.S. Food and Drug Administration. Inventia Healthcare ...

Thousands of bottles of blood pressure medications have been recalled by the FDA due to failing dissolution specifications. Learn more here.

The FDA has announced a nationwide recall of more than 11,000 bottles of chlorthalidone, a medication commonly prescribed to treat high blood pressure and fluid retention.